Skip to main content

Analyzing the Varied Application Areas of the Enzyme Market


Enzymes are defined as catalysts that are protein in nature and can enhance the rate of a chemical reaction by reducing the activation energy required for the reaction to take place. Enzymes are used across various industries, such as food and beverage, biofuel, cleaning products, and pharmaceuticals
The discovery of enzymes that have the ability to cleave and ligate the nucleic acid propelled the development of the genetic engineering industry. The use of enzymes in activities such as cloning, and gene editing has become a common phenomenon in agriculture and pharmaceutical industries. Further, enzymes are used in biotechnology to produce insects, droughts, and disease resistant crops and create organisms with desirable qualities and better commercial performance.

Highlighting the potential opportunities and the current factors contributing to the growing demand for enzymes, BIS Research published a market intelligence report titled, “Global Enzymes Industry – Analysis and Forecast (2018-2025).” According to the report, the global enzymes market was valued at $6.57 billion in 2017 and is projected to reach $10.63 billion by 2025, growing at a CAGR of 6.04% during the forecast period, 2018-2025.

The growth of the market can be attributed to the advantages of enzymes, such as flexibility to carry out reactions at normal temperature and pressure and the ability to eliminate the need for expensive equipment along with other factors, such as the use of natural enzymes, evolution of the enzyme technology, and the impact of genetically modified organism (GMO) crops.  

The study published by BIS Research examines the global enzymes market under different segments. The report categorizes the market based on product, end user, and region. On the basis of product, the market constitutes of five sub-segments, namely restriction enzymes, DNA Ligase, DNA Polymerase, Reverse Transcriptase, and others. Further, company profiles of leading market players, such as AB Enzymes, Agilent Technologies, and Amano Enzymes Inc., are included in the report.
With ongoing research and development activities, enzymes are expected to be used for applications such as drug discovery, nutraceuticals, and various other avenues in addition to the ones discussed above. 

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...